These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Current and future antiplatelet therapies: emphasis on preserving haemostasis. McFadyen JD; Schaff M; Peter K Nat Rev Cardiol; 2018 Mar; 15(3):181-191. PubMed ID: 29297508 [TBL] [Abstract][Full Text] [Related]
7. Antiplatelet therapy with glycoprotein IIb/IIIa receptor inhibitors and other novel agents. Schafer AI Tex Heart Inst J; 1997; 24(2):90-6. PubMed ID: 9205981 [TBL] [Abstract][Full Text] [Related]
8. Use of antiplatelet agents in sepsis: a glimpse into the future. Akinosoglou K; Alexopoulos D Thromb Res; 2014 Feb; 133(2):131-8. PubMed ID: 24103487 [TBL] [Abstract][Full Text] [Related]
9. Glycoprotein IIb/IIIa inhibitors improve outcome after coronary stenting in clopidogrel nonresponders: a prospective, randomized study. Cuisset T; Frere C; Quilici J; Morange PE; Mouret JP; Bali L; Moro PJ; Lambert M; Alessi MC; Bonnet JL JACC Cardiovasc Interv; 2008 Dec; 1(6):649-53. PubMed ID: 19463379 [TBL] [Abstract][Full Text] [Related]
10. Antiplatelet drugs: which targets for which treatments? Gachet C J Thromb Haemost; 2015 Jun; 13 Suppl 1():S313-22. PubMed ID: 26149041 [TBL] [Abstract][Full Text] [Related]
11. Novel Antiplatelet Agents in Cardiovascular Disease. Tscharre M; Michelson AD; Gremmel T J Cardiovasc Pharmacol Ther; 2020 May; 25(3):191-200. PubMed ID: 31960728 [TBL] [Abstract][Full Text] [Related]